Temozolomide 100 MG Injection [Temodar] — RxCUI 835948
RxNorm drug concept · Semantic branded drug
RxCUI 835948
Semantic branded drug · SBD
● Current RxNorm concept 7 FDA products
12 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI835948
Official nameTemozolomide 100 MG Injection [Temodar]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asTemodar 100 MG Injection
FDA products mapped7
Package NDCs mapped12
Reported Medicaid activity (SDUD)330 prescriptions · 5 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Temozolomide: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Temozolomide is a chemotherapy used to treat aggressive brain tumors — specifically glioblastoma (a fast-growing brain tumor) and anaplastic astrocytoma. It works by getting into c...
- What exactly is temozolomide treating, and why do I need it?
- Yes, it does matter. Swallow the capsules whole with a full glass of water — never open, crush, or chew them. Try to avoid taking them right after a high-fat meal, because fat can...
- How should I take the capsules — does it matter when I take them or whether I eat first?
🕸️ Concept Web — How Temozolomide 100 MG Injection [Temodar] Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Temozolomide 100 MG Injection [Temodar]
RxCUI 835948 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Temozolomide
37776IN
-
Temozolomide
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Temodar
261663BN
-
Temodar
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Temozolomide Injection
1724292SCDF -
Temozolomide Injectable Product
1161485SCDG -
Temozolomide Injection [Temodar]
1724294SBDF -
Temodar Injectable Product
1181413SBDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Temozolomide Injection
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Temozolomide 100 MG Injection
835945SCD -
Temozolomide 100 MG
330797SCDC -
Temozolomide 100 MG [Temodar]
574515SBDC
-
Temozolomide 100 MG Injection
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Temozolomide 100 MG Injection
SCD · 835945 -
Temozolomide 100 MG
SCDC · 330797 -
Temozolomide Injection
SCDF · 1724292 -
Temozolomide Injectable Product
SCDG · 1161485
Brand-Name Concepts
-
Temozolomide 100 MG [Temodar]
SBDC · 574515 -
Temozolomide Injection [Temodar]
SBDF · 1724294 -
Temodar Injectable Product
SBDG · 1181413 -
Temodar
BN · 261663
📦 FDA Products & Package NDCs
7 products · 12 package NDCs
12 package NDCs map to RxCUI 835948 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00085-1366-03 | 5 PACKET in 1 CARTON (0085-1366-03) / 1 CAPSULE in 1 PACKET... | TEMODAR | Merck Sharp & Dohme LLC | 1999-08-11 |
| 00085-1366-04 | 14 PACKET in 1 CARTON (0085-1366-04) / 1 CAPSULE in 1 PACKE... | TEMODAR | Merck Sharp & Dohme LLC | 1999-08-11 |
| 00085-1381-01 | 1 VIAL, SINGLE-USE in 1 CARTON (0085-1381-01) / 40 mL in 1... | TEMODAR | Merck Sharp & Dohme LLC | 2009-02-27 |
| 00085-1417-02 | 5 PACKET in 1 CARTON (0085-1417-02) / 1 CAPSULE in 1 PACKET... | TEMODAR | Merck Sharp & Dohme LLC | 1999-08-11 |
| 00085-1425-03 | 5 PACKET in 1 CARTON (0085-1425-03) / 1 CAPSULE in 1 PACKET... | TEMODAR | Merck Sharp & Dohme LLC | 1999-08-11 |
| 00085-1425-04 | 14 PACKET in 1 CARTON (0085-1425-04) / 1 CAPSULE in 1 PACKE... | TEMODAR | Merck Sharp & Dohme LLC | 1999-08-11 |
| 00085-1430-03 | 5 PACKET in 1 CARTON (0085-1430-03) / 1 CAPSULE in 1 PACKET... | TEMODAR | Merck Sharp & Dohme LLC | 1999-08-11 |
| 00085-1430-04 | 14 PACKET in 1 CARTON (0085-1430-04) / 1 CAPSULE in 1 PACKE... | TEMODAR | Merck Sharp & Dohme LLC | 1999-08-11 |
| 00085-1519-03 | 5 PACKET in 1 CARTON (0085-1519-03) / 1 CAPSULE in 1 PACKET... | TEMODAR | Merck Sharp & Dohme LLC | 1999-08-11 |
| 00085-1519-04 | 14 PACKET in 1 CARTON (0085-1519-04) / 1 CAPSULE in 1 PACKE... | TEMODAR | Merck Sharp & Dohme LLC | 1999-08-11 |
| 00085-3004-03 | 5 PACKET in 1 CARTON (0085-3004-03) / 1 CAPSULE in 1 PACKET... | TEMODAR | Merck Sharp & Dohme LLC | 1999-08-11 |
| 00085-3004-04 | 14 PACKET in 1 CARTON (0085-3004-04) / 1 CAPSULE in 1 PACKE... | TEMODAR | Merck Sharp & Dohme LLC | 1999-08-11 |
Observed labelers:
Merck Sharp & Dohme LLC (12)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J9328 | Temozolomide injection | 1 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.